Deep Vein Thrombosis and Pulmonary Embolism

Consultative Hemostasis and Thrombosis

Volumn , Issue , 2007, Pages 245-256

  Goldhaber, Samuel Z ^a,b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Venous Thromboembolism Research Group   (United States)

^c Anticoagulation Service   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61449233092     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141602401-9.10015-X     Document Type: Chapter

References (127)

1. SZ Goldhaber and CG Elliott (2003) Acute pulmonary embolism: Part I—Epidemiology, pathophysiology, and diagnosis. Circulation 108 2726-2729.
2. CG Elliott, SZ Goldhaber and RL Jensen (2005) Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest 128 3372-3376.
3. PS Wells, DR Anderson, J Bormanis, et al. (1997) Value of assessment of pretest probability of deep‐vein thrombosis in clinical management. Lancet 350 1795-1798.
4. WP Bundens, JJ Bergan, NA Halasz, et al. (1995) The superficial femoral vein: A potentially lethal misnomer. JAMA 274 1296-1298.
5. HV Joffe and SZ Goldhaber (2002) Upper extremity deep vein thrombosis. Circulation 106 1874-1880.
6. HV Joffe, N Kucher, VF Tapson, et al. (2004) Upper‐extremity deep vein thrombosis: A prospective registry of 592 patients. Circulation 110 1605-1611.
7. SM Stevens, CG Elliott, KJ Chan, et al. (2004) Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis. Ann Intern Med 140 985-991.
8. PA Loud, DS Katz, L Belfi, et al. (2005) Imaging of deep venous thrombosis in suspected pulmonary embolism. Semin Roentgenol 40 33-40.
9. PS Wells, AW Lensing, BL Davidson, et al. (1995) Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: A meta‐analysis. Ann Intern Med 122 47-53.
10. LM Jongbloets, AW Lensing, MM Koopman, et al. (1994) Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis. Lancet 343 1142-1144.
11. JB Stern, M Abehsera, D Grenet, et al. (2002) Detection of pelvic vein thrombosis by magnetic resonance angiography in patients with acute pulmonary embolism and normal lower limb compression ultrasonography. Chest 122 115-121.
12. DG Fraser, AR Moody, PS Morgan, et al. (2002) Diagnosis of lower‐limb deep venous thrombosis: A prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 136 89-98.
13. R Hull, J Hirsh, DL Sackett, et al. (1981) Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 64 622-625.
14. C Kabrhel, CA Camargo Jr and SZ Goldhaber (2005) Clinical gestalt and the diagnosis of pulmonary embolism: Does experience matter? Chest 127 1627-1630.
15. PS Wells, JS Ginsberg, DR Anderson, et al. (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 129 997-1005.
16. A van Belle, HR Buller, MV Huisman, et al. (2006) Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, d‐dimer testing, and computed tomography. JAMA 295 172-179.
17. PD Stein, SZ Goldhaber, JW Henry and AC Miller (1996) Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 109 78-81.
18. PD Stein, SZ Goldhaber and JW Henry (1995) Alveolar‐arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 107 139-143.
19. MD Brown, BH Rowe, MJ Reeves, et al. (2002) The accuracy of the enzyme‐linked immunosorbent assay d‐dimer test in the diagnosis of pulmonary embolism: A meta‐analysis. Ann Emerg Med 40 133-144.
20. PD Stein, RD Hull, KC Patel, et al. (2004) d‐dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med 140 589-602.
21. KL Dunn, JP Wolf, DM Dorfman, et al. (2002) Normal d‐dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 40 1475-1478.
22. M Righini, D Aujesky, PM Roy, et al. (2004) Clinical usefulness of d‐dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism. Arch Intern Med 164 2483-2487.
23. A Gottschalk, HD Sostman, RE Coleman, et al. (1993) Ventilation‐perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 34 1119-1126.
24. PD Stein, F Kayali and RE Olson (2004) Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism. Am J Cardiol 93 1316-1317.
25. SZ Goldhaber (2005) How chest CT for the diagnosis of pulmonary embolism (PE) has changed my professional life: Reflections from a PE doctor. Semin Roentgenol 40 8-10.
26. SZ Goldhaber (2005) Multislice computed tomography for pulmonary embolism: A technological marvel. N Engl J Med 352 1812-1814.
27. UJ Schoepf, SZ Goldhaber and P Costello (2004) Spiral computed tomography for acute pulmonary embolism. Circulation 109 2160-2167.
28. JG Ravenel, F Kipfmueller and UJ Schoepf (2005) CT angiography with multidetector‐row CT for detection of acute pulmonary embolus. Semin Roentgenol 40 11-19.
29. MJ van Strijen, W de Monye, J Schiereck, et al. (2003) Single‐detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: A multicenter clinical management study of 510 patients. Ann Intern Med 138 307-314.
30. LK Moores, WL Jackson Jr, AF Shorr and JL Jackson (2004) Meta‐analysis: Outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med 141 866-874.
31. R Quiroz, N Kucher, KH Zou, et al. (2005) Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: A systematic review. JAMA 293 2012-2017.
32. PD Stein, C Athanasoulis, A Alavi, et al. (1992) Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85 462-468.
33. SZ Goldhaber (2002) Echocardiography in the management of pulmonary embolism. Ann Intern Med 136 691-700.
34. P Pruszczyk, A Torbicki, A Kuch‐Wocial, et al. (2001) Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism. Heart 85 628-634.
35. EJR van Beek, JM Wild, C Fink, et al. (2003) MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 18 627-640.
36. N Kucher and SZ Goldhaber (2003) Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 108 2191-2194.
37. S Konstantinides, A Geibel, M Olschewski, et al. (2002) Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 1263-1268.
38. N Kucher, D Wallmann, A Carone, et al. (2003) Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. Eur Heart J 24 1651-1656.
39. K Janata, M Holzer, AN Laggner and M Mullner (2003) Cardiac troponin T in the severity assessment of patients with pulmonary embolism: Cohort study. BMJ 326 312-313.
40. P Pruszczyk, A Bochowicz, A Torbicki, et al. (2003) Cardiac troponin T monitoring identifies high‐risk group of normotensive patients with acute pulmonary embolism. Chest 123 1947-1952.
41. E Giannitsis, M Muller‐Bardorff, V Kurowski, et al. (2000) Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102 211-217.
42. T Meyer, L Binder, N Hruska, et al. (2000) Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 36 1632-1636.
43. N Kucher, G Printzen, T Doernhoefer, et al. (2003) Low pro‐brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 107 1576-1578.
44. N Kucher, G Printzen and SZ Goldhaber (2003) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 2545-2547.
45. N Nagaya, T Nishikimi, Y Okano, et al. (1998) Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 202-208.
46. P Pruszczyk, M Kostrubiec, A Bochowicz, et al. (2003) N‐terminal pro‐brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 22 649-653.
47. M ten Wolde, II Tulevski, JW Mulder, et al. (2003) Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 107 2082-2084.
48. II Tulevski, A Hirsch, BJ Sanson, et al. (2001) Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 86 1193-1196.
49. L Binder, B Pieske, M Olschewski, et al. (2005) N‐terminal pro‐brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112 1573-1579.
50. A Ribeiro, P Lindmarker, A Juhlin‐Dannfelt, et al. (1997) Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134 479-487.
51. A Torbicki, N Galie, A Covezzoli, et al. (2003) Right heart thrombi in pulmonary embolism: Results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 41 2245-2251.
52. N Kucher, E Rossi, M De Rosa and SZ Goldhaber (2005) Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 165 1777-1781.
53. S Konstantinides, A Geibel, W Kasper, et al. (1998) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97 1946-1951.
54. A Torbicki, N Galie, A Covezzoli, et al. (2003) Right heart thrombi in pulmonary embolism: Results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol 41 2245-2251.
55. T Scridon, C Scridon, H Skali, et al. (2005) Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 96 303-305.
56. R Quiroz, N Kucher, UJ Schoepf, et al. (2004) Right ventricular enlargement on chest computed tomography: Prognostic role in acute pulmonary embolism. Circulation 109 2401-2404.
57. UJ Schoepf, N Kucher, F Kipfmueller, et al. (2004) Right ventricular enlargement on chest computed tomography: A predictor of early death in acute pulmonary embolism. Circulation 110 3276-3280.
58. DP Brandjes, H Heijboer, HR Buller, et al. (1992) Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal‐vein thrombosis. N Engl J Med 327 1485-1489.
59. E Bernardi, A Piccioli, G Oliboni, et al. (2000) Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism—An overview. Thromb Haemost 84 22-26.
60. RA Raschke, BM Reilly, JR Guidry, et al. (1993) The weight‐based heparin dosing nomogram compared with a “standard care” nomogram: A randomized controlled trial. Ann Intern Med 119 874-881.
61. J Fanikos, C Stapinski, S Koo, et al. (2004) Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol 94 532-535.
62. DR Hirsch, TH Lee, RB Morrison, et al. (1996) Shortened hospitalization by means of adjusted‐dose subcutaneous heparin for deep venous thrombosis. Am Heart J 131 276-280.
63. P Prandoni, M Carnovali and A Marchiori (2004) Subcutaneous adjusted‐dose unfractionated heparin vs fixed‐dose low‐molecular‐weight heparin in the initial treatment of venous thromboembolism. Arch Intern Med 164 1077-1083.
64. MK Gould, AD Dembitzer, RL Doyle, et al. (1999) Low‐molecular‐weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A meta‐analysis of randomized, controlled trials. Ann Intern Med 130 800-809.
65. MK Gould, AD Dembitzer, GD Sanders and AM Garber (1999) Low‐molecular‐weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: A cost‐effectiveness analysis. Ann Intern Med 130 789-799.
66. R Raschke, J Hirsh and JR Guidry (2003) Suboptimal monitoring and dosing of unfractionated heparin in comparative studies with low‐molecular‐weight heparin. Ann Intern Med 138 720-723.
67. M Levine, M Gent, J Hirsh, et al. (1996) A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis. N Engl J Med 334 677-681.
68. G Merli, TE Spiro, CG Olsson, et al. (2001) Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 134 191-202.
69. PS Wells, DR Anderson, MA Rodger, et al. (2005) A randomized trial comparing 2 low‐molecular‐weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 165 733-738.
70. HK Breddin, V Hach‐Wunderle, R Nakov and VV Kakkar (2001) Effects of a low‐molecular‐weight heparin on thrombus regression and recurrent thromboembolism in patients with deep‐vein thrombosis. N Engl J Med 344 626-631.
71. G Simonneau, H Sors, B Charbonnier, et al. (1997) A comparison of low‐molecular‐weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 337 663-669.
72. P Mismetti, S Quenet, M Levine, et al. (2005) Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: An individual patient data meta‐analysis. Chest 128 2203-2210.
73. DJ Quinlan, A McQuillan and JW Eikelboom (2004) Low‐molecular‐weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta‐analysis of randomized, controlled trials. Ann Intern Med 140 175-183.
74. AY Lee, MN Levine, RI Baker, et al. (2003) Low‐molecular‐weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 146-153.
75. N Kucher, R Quiroz, S McKean, et al. (2005) Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med 10 251-256.
76. N Kucher, R Quiroz, S McKean, et al. (2005) Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med 10 251-256.
77. HR Buller, BL Davidson, H Decousus, et al. (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: A randomized trial. Ann Intern Med 140 867-873.
78. HR Buller, BL Davidson, H Decousus, et al. (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349 1695-1702.
79. S Konstantinides, A Geibel, G Heusel, et al. (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347 1143-1150.
80. S Wan, DJ Quinlan, G Agnelli and JW Eikelboom (2004) Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: A meta‐analysis of the randomized controlled trials. Circulation 110 744-749.
81. N Kucher, E Rossi, M De Rosa and SZ Goldhaber (2006) Massive pulmonary embolism. Circulation 113 577-582.
82. MC Janssen, H Wollerscheim, LJ Schultze‐Kool and T Thein (2005) Local and systemic thrombolytic therapy for acute deep vein thrombosis. Neth J Med 63 81-90.
83. G Acharya, K Singh, JB Hansen, et al. (2005) Catheter‐directed thrombolysis for the management of postpartum deep vein thrombosis. Acta Obstet Gynecol Scand 84 155-158.
84. MK Laiho, A Oinonen, N Sugano, et al. (2004) Preservation of venous valve function after catheter‐directed and systemic thrombolysis for deep vein thrombosis. Eur J Vasc Endovasc Surg 28 391-396.
85. F Couturaud and C Kearon (2001) Treatment of deep vein thrombosis. Semin Vasc Med 1 43-54.
86. SM Arcasoy and A Vachani (2003) Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med 24 73-91.
87. PS Wells and AJ Forster (2001) Thrombolysis in deep vein thrombosis: Is there still an indication? Thromb Haemost 86 499-508.
88. M Leacche, D Unic, SZ Goldhaber, et al. (2005) Modern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 129 1018-1023.
89. R Sukhija, WS Aronow, J Lee, et al. (2005) Association of right ventricular dysfunction with in‐hospital mortality in patients with acute pulmonary embolism and reduction in mortality in patients with right ventricular dysfunction by pulmonary embolectomy. Am J Cardiol 95 695-696.
90. N Meneveau, MF Seronde, MC Blonde, et al. (2006) Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 129 1043-1050.
91. SZ Goldhaber (1998) Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest 114 1237-1238.
92. N Kucher, S Windecker, Y Banz, et al. (2005) Percutaneous catheter thrombectomy device for acute pulmonary embolism: In vitro and in vivo testing. Radiology 236 852-858.
93. G Pacouret, D Alison, J.M. Pottier J‐M, et al. (1997) Free‐floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. Arch Intern Med 157 305-308.
94. PD Stein, F Kayali and RE Olson (2004) Twenty‐one‐year trends in the use of inferior vena cava filters. Arch Intern Med 164 1541-1545.
95. PD Stein, M Alnas, E Skaf, et al. (2004) Outcome and complications of retrievable inferior vena cava filters. Am J Cardiol 94 1090-1093.
96. MR Jaff, SZ Goldhaber and VF Tapson (2005) High utilization rate of vena cava filters in deep vein thrombosis. Thromb Haemost 93 1117-1119.
97. H Decousus, A Leizorovicz, F Parent, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep‐vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338 409-415.
98. Eight‐year follow‐up of patients with permanent vena cava filters in the prevention of pulmonary embolism (2005) The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 112 416-422.
99. RH White, H Zhou, J Kim and PS Romano (2000) A population‐based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 160 2033-2041.
100. KE Wood (2002) Major pulmonary embolism: Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121 877-905.
101. G Piazza and SZ Goldhaber (2005) The acutely decompensated right ventricle: Pathways for diagnosis and management. Chest 128 1836-1852.
102. N Kucher and SZ Goldhaber (2005) Management of massive pulmonary embolism. Circulation 112 e28-e32.
103. MM Hoeper, E Mayer, G Simonneau and LJ Rubin (2006) Chronic thromboembolic pulmonary hypertension. Circulation 113 2011-2020.
104. V Pengo, AW Lensing, MH Prins, et al. (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350 2257-2264.
105. SW Jamieson, DP Kapelanski, N Sakakibara, et al. (2003) Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann Thorac Surg 76 1457-1462. discussion 1462–1464.
106. JA Feinstein, SZ Goldhaber, JE Lock, et al. (2001) Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103 10-13.
107. LA Linkins, PT Choi and JD Douketis (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta‐analysis. Ann Intern Med 139 893-900.
108. DM Witt, MA Sadler, RL Shanahan, et al. (2005) Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 127 1515-1522.
109. C Heneghan, P Alonso‐Coello, JM Garcia‐Alamino, et al. (2006) Self‐monitoring of oral anticoagulation: A systematic review and meta‐analysis. Lancet 367 404-411.
110. S Eichinger, A Weltermann, E Minar, et al. (2004) Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 164 92-96.
111. PA Kyrle, E Minar, C Bialonczyk, et al. (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350 2558-2563.
112. T Baglin, R Luddington, K Brown and C Baglin (2004) High risk of recurrent venous thromboembolism in men. J Thromb Haemost 2 2152-2155.
113. SC Christiansen, SC Cannegieter, T Koster, et al. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 293 2352-2361.
114. JS Miles, JP Miletich, SZ Goldhaber, et al. (2001) G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol 37 215-218.
115. S Eichinger, A Stumpflen, M Hirschl, et al. (1998) Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 80 566-569.
116. MA Crowther, JS Ginsberg, J Julian, et al. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 1133-1138.
117. P Simioni, P Prandoni, AW Lensing, et al. (1997) The risk of recurrent venous thromboembolism in patients with an Arg506→Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med 336 399-403.
118. S Eichinger, A Weltermann, C Mannhalter, et al. (2002) The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Arch Intern Med 162 2357-2360.
119. S Schulman, AS Rhedin, P Lindmarker, et al. (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332 1661-1665.
120. S Schulman, S Granqvist, M Holmstrom, et al. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 336 393-398.
121. D Ost, J Tepper, H Mihara, et al. (2005) Duration of anticoagulation following venous thromboembolism: A meta‐analysis. JAMA 294 706-715.
122. C Kearon, JS Ginsberg, MJ Kovacs, et al. (2003) Comparison of low‐intensity warfarin therapy with conventional‐intensity warfarin therapy for long‐term prevention of recurrent venous thromboembolism. N Engl J Med 349 631-639.
123. PM Ridker, SZ Goldhaber, E Danielson, et al. (2003) Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348 1425-1434.
124. S Schulman, K Wahlander, T Lundstrom, et al. (2003) Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 349 1713-1721.
125. P Prandoni, AW Lensing, MH Prins, et al. (2002) Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 137 955-960.
126. G Palareti, C Legnani, B Cosmi, et al. (2003) Predictive value of d‐dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108 313-318.
127. S Eichinger, E Minar, C Bialonczyk, et al. (2003) d‐dimer levels and risk of recurrent venous thromboembolism. JAMA 290 1071-1074.